Jodi B Segal

机构：Johns Hopkins University, Johns Hopkins Medicine · ORCID：0000-0003-3978-9662

发表论文 550 篇 · 总被引 18129 次 · h-index 71

代表论文

• Process guide for inferential studies using healthcare data from routine clinical practice to evaluate causal effects of drugs (PRINCIPLED): considerations from the FDA Sentinel Innovation Center (2024 · BMJ · 被引 61)
• Harm-Benefit Balance of Immune Checkpoint Inhibitors in Non–Small Cell Lung Cancer (2025 · JAMA Oncology · 被引 13)
• Addressing Missingness in Predictive Models That Use Electronic Health Record Data (2025 · Annals of Internal Medicine · 被引 7)
• Population‐Based Validation Results From the Drug Repurposing for Effective Alzheimer's Medicines (DREAM) Study (2025 · Clinical Pharmacology & Therapeutics · 被引 7)
• Comparative safety and effectiveness of apixaban and rivaroxaban for treatment of cancer-associated venous thromboembolism: A retrospective cohort study (2025 · PLoS Medicine · 被引 5)
• Validation of Immune‐Related Adverse Event ( irAE ) Case Definitions in a Real‐World Lung Cancer Population (2025 · Pharmacoepidemiology and Drug Safety · 被引 4)